Cullen Capital Management, LLC Novartis Ag Transaction History
Cullen Capital Management, LLC
- $8.45 Billion
- Q4 2024
A detailed history of Cullen Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cullen Capital Management, LLC holds 2,156,619 shares of NVS stock, worth $238 Million. This represents 2.48% of its overall portfolio holdings.
Number of Shares
2,156,619
Previous 2,251,968
4.23%
Holding current value
$238 Million
Previous $259 Million
18.98%
% of portfolio
2.48%
Previous 2.82%
Shares
32 transactions
Others Institutions Holding NVS
# of Institutions
1,478Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.35 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.22 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$903 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$758 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$616 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $237B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...